domingo, 24 de abril de 2022

Ipilimumab/Nivolumab Therapy in Patients With Metastatic Pancreatic or Biliary Cancer With Homologous Recombination Deficiency Pathogenic Germline Variants G Terrero et al, JAMA Oncology, April 21, 2022

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario